Clinical Trials in Southeast Asia 2012 (CTSE 2012) November 22, 2012

More and More companies in India are looking to conduct clinical trials in Southeast Asia due to the growing market potential, a well defined and speedy regulatory process and the high quality of clinical trials, compatible with USFDA and EMA requirements.
In fact Southeast Asia is one of the fastest emerging hub for Clinical Trials in the world. For more than a decade, the emerging markets of the Southeast Asia region have held special promise for the global biopharmaceutical industry. Driven by a combination of rapidly expanding economies, technological innovation and a talented workforce, the region has seen explosive growth in both economic and political power during the past 10 years.
​
A range of factors — from deregulation and better trade links, to improved access and the rise of medical tourism — have enabled markets such as Malaysia, Vietnam, Indonesia and others to take on increasingly important roles in this region. Countries such as Singapore and Malaysia have all identified the biopharmaceutical industry as a strategic sector worthy of public infrastructure investment and support.

Indian and multinational Big pharma and Biotech companies are taking their trials to Southeast Asia due to stringent regulatory approvals and increase in denials for conducting Clinical Trials in India.

​The goal of this program is to showcase the potential of Clinical Trial scenario in Southeast Asia. The regulatory agencies, their expectations and their process for approvals are some of the key points in this conference. Delegates include Directors, VPs, Senior Medical Advisors and senior staff of Regulatory affairs from pharma and biotech companies and also couple of Clinical Research Organizations as solution providers with expertise in this region.

​A golden opportunity at your doorstep:
The clinical trials in Southeast Asia 2012 is India's premier event for those interested in the rapidly growing clinical trials market in this region.

As a geographically focused business meeting it has a few parallels in the depth of its coverage of Asian issues and the networking opportunities for those interested in Southeast Asia.
The conference advisory board and the speaker faculty are leading experts from the region, with hands-on experience in clinical trials in Southeast Asia. The Agenda tackles the key strategic, regulatory and scientific issues impacting the industry today as well as perspectives about the future.
The format of the conference is designed to deliver a CXO / VP level, interactive conference experience over an innovative one day program.

Official Website: http://www.ssiconnects.org